Amneal Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference Transcript
All right. Great. Why don't we get started? Thank you for -- everyone, for joining us. My name is Nathan Rich, and I follow the drug supply chain stock here at Goldman. We're happy to have with us today, Amneal Pharmaceuticals. To my immediate left is Rob Stewart, President and CEO; and to my far left, Todd Branning, SVP and CFO of the company. Mark Donohue from IR is also in the audience with us today.
The format's just going to be a fireside chat. I think we'll just jump right into questions. If anyone in the audience has a question over the course of the presentation, we'll stop a couple of times. Just raise your hand, and we'll get you a mic. So with that, why don't we get started?
Questions & Answers
I guess one of the big questions on people's minds, just in general, when they're looking at the generic space, I think that -- how would you kind of help people get comfortable
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
